| Trial ID: | L0736 |
| Source ID: | IRCT20181119041701N1
|
| Associated Drug: |
Stevia Dry Leaves
|
| Title: |
the Effect of Stevia Dry Leaves on Serum Levels of Liver Enzymes, Lipid Profile, Glycemic Indicators, Adiponectin and Leptin in Overweight and Obese Diabetic Patients with Non-Alcoholic Fatty Liver
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Condition 1: Diabetes. Condition 2: Non-alcoholic fatty liver. <br>Type 2 diabetes mellitus without complications <br>Fatty (change of) liver, not elsewhere classified;E11.9;K76.0
|
| Interventions: |
Intervention 1: Intervention group: Everyone will receive 2 capsules 250 mg stevia per day for 8 weeks. Intervention 2: Control group: Everyone will receive placebo, starch, 2 capsules 250 mg per day for 8 weeks.
|
| Outcome Measures: |
Lipid profile. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Laboratory test.;Liver Enzymes. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Laboratory test.;Fasting blood sugar. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Laboratory test.;Insulin resistance. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Using the HOMA-IR formula.;Leptin. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Laboratory test.;Adiponectin. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Laboratory test.;Body mass index. Timepoint: Before and after 8 weeks of intervention. Method of measurement: The weight ratio in kilograms to the second power of height in meters.Systolic blood pressure. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Mercury pressure gauge.;Diastolic blood pressure. Timepoint: Before and after 8 weeks of intervention. Method of measurement: Mercury pressure gauge.
|
| Sponsor/Collaborators: |
Ahvaz University of Medical Sciences
|
| Gender: |
All
|
| Age: |
20 years60 years
|
| Phases: |
Phase 3
|
| Enrollment: |
50
|
| Study Type: |
interventional
|
| Study Designs: |
Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Simple randomization? Use random numbers Table, Blinding description: The type of blindness in our study will be doub
|
| Start Date: |
05/07/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
26 August 2019
|
| Locations: |
Iran (Islamic Republic of)
|
| URL: |
http://en.irct.ir/trial/35455
|
